Furthermore, we analyzed the antibody levels of T2DM patients treated with insulin (among the hypoglycemic drugs, only insulin was used) and those whose regimens did not include insulin (their regimens also did not contain other hypoglycemic drugs). The gene discussed is INS; the disease is type 2 diabetes mellitus.